2021-CH-2117d0d81307fd8f

✅ 正解解析

正解是 D。雖然 CTD-ILD 與 IPF 兩者皆可表現出典型的 UIP pattern（即 basilar 且 subpleural 分佈的 reticulation 與 honeycombing），但在高解析度電腦斷層 (HRCT) 上，有三個特定的徵象具有高度特異性，能提示病因為 CTD 相關而非單純的 IPF。這三個徵象分別是：『Anterior upper lobe sign』（纖維化集中於上葉前側）、『Exuberant honeycombing sign』（纖維化區域中有極高比例，通常大於 70%，表現為廣泛的蜂窩狀改變），以及『Straight-edge sign』（肺底的纖維化病灶與上方相對正常的肺組織在頭尾方向呈現銳利平直的交界）。因為 A、B、C 三個選項皆為 CTD-UIP 的經典特徵，故選 D。

📝 選項逐一判讀

A 正確干擾選項

Anterior upper lobe sign 指的是在上肺葉中，纖維化病灶相對集中在 anterior aspect 而避開 posterior aspect。這在 CTD-ILD（尤其是類風濕性關節炎相關的 UIP）中較常見，具有良好的鑑別力。

💡 出題原因：測試考生對 CTD-UIP 上葉不尋常分佈特徵的認識。

B 正確干擾選項

Exuberant honeycombing sign 指的是在纖維化的病灶中，honeycombing 的佔比極高（通常定義為佔纖維化區域 >70%）。這種過度密集的蜂窩狀改變強烈暗示 CTD 相關的 UIP。

💡 出題原因：測試考生對 honeycombing 程度在不同病因間差異的理解。

C 正確干擾選項

Straight-edge sign 是指肺底部的纖維化與上方無病灶的肺組織之間，在 craniocaudal plane 呈現一個非常銳利、平直的交界（sharp demarcation）。這個徵象對於 CTD-UIP 有高度特異性。

💡 出題原因：測試考生對 CTD-UIP 特有邊界形態（demarcation pattern）的記憶。

D 正確正答

由於 A、B、C 三個徵象皆為文獻中確認可有效區別 CTD-ILD 與 IPF 的 specific CT signs，因此『All of the above』為正確答案。

💡 出題原因：作為本題的綜合正確選項，要求考生完整掌握這三個鑑別徵象。

📚 參考文獻對齊

[REF-SUPPORTED] 題目引用的文獻 (AJR Vol.210, Issue.2, 2018, Pages 307-313) 正是正式定義並驗證了 Anterior upper lobe sign、Exuberant honeycombing sign 與 Straight-edge sign 對於區分 CTD-UIP 與 IPF-UIP 之臨床價值的經典論文。[STANDARD TEACHING] 這些徵象目前已納入胸腔影像學中評估 interstitial lung disease 的標準教學與進階判讀指引中。

CT Features of the Usual Interstitial Pneumonia Pattern: Differentiating Connective Tissue Disease–Associated Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis [journal article]
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline [clinical guideline]
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline [clinical guideline]
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases [clinical guideline]
📝 AJR 2018 directly supports D: all three signs were significantly more common in CTD-UIP than IPF-UIP; individual sign sensitivity was low (22.2-25.4%) and specificity was high (87.2-94.0%).
📝 ATS guidance reproduces the same three CTD-UIP clues, so the core answer remains current and version-stable.
📝 ATS 2018 IPF diagnostic guidance lists dilated esophagus and pleural effusion/thickening as ancillary clues to an alternative diagnosis including CTD, but treats predominant ground-glass opacity as an alternative-diagnosis pattern rather than a classic UIP clue.
📝 ACR/CHEST 2023 shows SARD-ILD treatment is subtype-specific: mycophenolate/azathioprine/rituximab/cyclophosphamide are first-line options, nintedanib is first-line for SSc-ILD, and RA-ILD has no consensus on first-line nintedanib.

🔍 QA 審核 APPROVED_WITH_MINOR_REVISION

修訂指示：In `correct_explanation`, `options_review[C]`, `knowledge_connections`, and the Anki mechanism/reminders, change the language from definitive/generalized to 'supportive high-specificity, low-sensitivity CTD-UIP clues,' add the missing 'no substantial lateral extension' element of the straight-edge definition, and remove the blanket CTD-ILD treatment / `GGO > reticulation` heuristic because current AJR/ATS/ACR sources do not support it as a universal teaching rule for this item.

審核摘要：No escalation is required. Optional thoracic radiology or ILD-clinic review would only be useful if you want to keep or expand the supplemental management pearl beyond the proposed edits.

驗證建議：Re-check AJR 2018 Table 3 and the sign definitions, then compare the supplemental pearl against ATS 2018 IPF diagnostic Table 4 and ACR/CHEST 2023 first-line SARD-ILD treatment recommendations before publishing.

QA 信心：93% HIGH

✅ Logic direction and stem interpretation：The solver correctly treats this as a POSITIVE stem and correctly resolves the all-of-the-above structure: D is right only if A, B, and C are each more common in CTD-UIP than in IPF-UIP.
⚠️ Correct answer validity and mechanistic explanation：D is correct per Chung et al. AJR 2018 and later ATS guidance, but the mechanism should explicitly frame these as supportive high-specificity, low-sensitivity clues rather than definitive discriminators; the straight-edge definition also needs the missing 'no substantial lateral extension' element.
✅ Complete and specific option-by-option coverage：All four options are addressed specifically. A-C are individually explained as true CTD-UIP-associated signs, and D is justified as the marked answer because this is an all-of-the-above item.
✅ Cross-option consistency and absence of internal contradiction：There is no material internal contradiction. Calling A-C individually true while D remains the selected answer is coherent for a single-best-answer MCQ with an all-of-the-above choice.
✅ Feature weighting and decisive feature：The decisive exam feature is presented correctly: the answer depends on the fact that all three named signs favor CTD-UIP over IPF-UIP, not on picking one uniquely superior sign.
⚠️ Unsafe heuristics or over-generalized rules：The supplemental pearl is pedagogically too broad. Current ACR/CHEST guidance does not support teaching 'CTD-ILD usually needs immunosuppression' as a universal rule, and ATS IPF diagnostic guidance treats predominant GGO as an alternative-diagnosis clue rather than a classic CTD-UIP sign.
✅ Reference alignment and guideline / version correctness：The cited reference metadata matches AJR 2018;210(2):307-313, and the same three signs are reproduced in official ATS material without version conflict. No staging/classification version problem was identified.
⚠️ Anki fidelity, compression quality, and structural completeness：The Anki front exactly matches the stem and the answer preserves official answer D, but the compressed teaching inherits the same over-broad treatment heuristic and does not warn that these signs are suggestive rather than sensitive or definitive.